GGrantIndex
← Search

CLINICAL TRIAL: PHASE I PRIME-BOOST STUDY OF VI POLYSACCHARIDE TYPHOID VACCINE A

$43,806M01FY2008RRNIH

University Of Maryland Baltimore, Baltimore MD

Investigators

Linked publications & trials

View original record on NIH RePORTER →